Nasdaq1mon
Ascendis Pharma Reports Positive Week 26 Results for TransCon hGH in Turner Syndrome Clinical Trial
The trial involved 49 children who were randomized ... is the most common clinical feature of Turner syndrome. Clinical manifestations of Turner syndrome affect multiple organ systems and are ...
Yahoo Finance1mon
New InsiGHTS Trial of TransCon™ hGH (Lonapegsomatropin) in Turner Syndrome Achieved Primary Objective at Week 26
In the trial, TransCon hGH was generally safe ... is the most common clinical feature of Turner syndrome. Clinical manifestations of Turner syndrome affect multiple organ systems and are ...
Stockhouse1mon
New InsiGHTS Trial of TransCon(TM) hGH (Lonapegsomatropin) in Turner Syndrome Achieved Primary Objective at Week 26
In the trial, TransCon hGH was generally safe and well tolerated ... is the most common clinical feature of Turner syndrome. Clinical manifestations of Turner syndrome affect multiple organ systems ...
Finanznachrichten1mon
Ascendis Pharma: New InsiGHTS Trial of TransCon hGH (Lonapegsomatropin) in Turner Syndrome Achieved Primary Objective at Week 26
In the trial, TransCon hGH was generally safe ... is the most common clinical feature of Turner syndrome. Clinical manifestations of Turner syndrome affect multiple organ systems and are ...
Taiwan News1mon
New InsiGHTS Trial of TransCon™ hGH (Lonapegsomatropin) in Turner Syndrome Achieved Primary Objective at Week 26
In the trial, TransCon hGH was generally safe and well tolerated ... is the most common clinical feature of Turner syndrome. Clinical manifestations of Turner syndrome affect multiple organ systems ...